Selos Therapeutics Inc. (NASDAQ: SEEL) Receives FDA Approval For IND To...

0
Selos Therapeutics Inc. (NASDAQ: SEEL) has announced that the FDA has accepted its Investigational New Drug application to evaluate SLS-005 (trehalose injection, 90.5mg/mL for...

DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology

0
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...

Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.

0
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....

Popular News

MAKE IT MODERN

LATEST REVIEWS

Citius Pharmaceuticals Inc. (NASDAQ: CTXR) Finalizes Patient Enrolment In Pivotal Phase...

0
Citius Pharmaceuticals Inc. (NASDAQ: CTXR) has announced that it has finalized patient enrolment in the Pivotal Phase 3 study of its engineered IL-2-diphtheria toxin...

MAKE IT MODERN

PERFORMANCE TRAINING

AIM ImmunoTech Inc. (NYSEAMERICAN:AIM) Announce Promising Survival Results Of Study Of Ampligen In Advanced...

0
AIM ImmunoTech Inc (NYSEAMERICAN:AIM) has announced that it has received a statistically significant promising pancreatic cancer survival results from its multi-year Early Access Program...

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) Commences Clinical Trials For REGN-COV2 As A Potential COVID-19 Vaccine

0
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced on Thursday that it kick-started REGN-COV2 clinical trials, aiming to test the antibody combination's ability to prevent COVID-19. The announcement,...

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) Receive Approval From European Commission For Expanded KALYDECO® Label

0
Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) has announced that it has received approval from the EU for KALYDECO® granules label extension. The extension includes treatment of...

Qualigen Therapeutics Inc (NASDAQ: OLGN) Presents Three Posters at the American Association of Cancer...

0
Qualigen Therapeutics (NASDAQ: OLGN) announced the presentation of three posters at the American Association of Cancer Research, New Orleans.

Acurx Pharmaceuticals Inc. (NASDAQ: ACXP) Announce Publication of Ibezapolstat Phase 2a Clinical Study Results...

0
Acurx Pharmaceuticals Inc. (NASDAQ: ACXP) has announced the publication of positive results of its Phase 2a clinical study in Clinical Infectious Disease, the official...

MAKE IT MODERN

POPULAR

romabet mahbet پین باهیس bettingmagazine.org بت کارت یاس بت yekbet megapari onjabet alvinbet betboro betfa بت فوروارد 1xbet 1win betwinner 4shart.com 1xbetgiris.cam وان کیک بت وین بت ریتزوبت 1xbet-ir.com.co وان ایکس بت بت فوروارد